MedTrace Logo

Vascular Endothelial Growth Factor (VEGF) Levels in Brain Tumor Patients

NCT00985036 · Status: WITHDRAWN · Type: OBSERVATIONAL

Last updated 2012-04-24

No results posted yet for this study

Summary

Objectives: This study is looking at the level of vascular endothelial growth factor (VEGF) circulating in the blood stream of patients diagnosed with either a meningioma or a glioma. The questions that will be addressed include:

1. Can VEGF level alert us to tumor progression or recurrence before MRI changes occur?
2. Is the VEGF level an indicator of the response to treatment?
3. Does the VEGF level correlate with tumor histology and behavior?
4. Is there a relationship between VEGF level and outcome?

Conditions

Interventions

PROCEDURE

Blood test

an additional vial of blood will be obtained at the time of MRI or at the time of routine blood tests ordered by the medical oncologist. In other words, there will be no extra needle sticks. Just an extra vial of blood will be taken during a routine blood test

Sponsors & Collaborators

  • Upper Michigan Brain Tumor Center

    collaborator OTHER

  • Marquette General Health System

    lead OTHER

Principal Investigators

  • Richard A Rovin, MD, FACS · Upper Michigan Brain Tumor Center

  • Robert J Winn, PhD · Northern Michigan University

  • Suresh Nukala, MD · Marquette General Health Systems

Eligibility

Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-09-30
Primary Completion
2011-09-30
Completion
2012-01-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00985036 on ClinicalTrials.gov